No new safety signals emerged, and it appears to share the classs risk-benefit profile
Estimates vary widely, with around 5-40% of people reporting ongoing digestive symptoms after cholecystectomy, depending on how theyre defined
What is the dosage from the label
But lets clear one thing up: GLP-1 treatments
Significantly, among suboptimally controlled GLP-1RA users, the vast majority received treatment intensification (almost 89.0%), whereas, worryingly, among non-GLP-1 users, nearly half did not receive treatment intensification during follow-up
However, we cannot exclude that commitment of the FoB compartment and the reflection of wild-type MZB-like properties by FoB in B cell-specific Gclc -deficient hosts, might be the consequence of a physiological attempt to fill the empty MZB compartment